Generation of an induced pluripotent stem cell line from a patient with immune checkpoint inhibitor-induced myocarditis and concurrent type I diabetes
Lee, M. K.; Vitale, M. R.; Sun, Y.; Wagner, N. S.; Sundar, H. A.; Sun, S.; Ramchandran, A.; Khatua, S.; Chou, H.; Huang, Y. V.; Zhuge, Y.; Wu, J. C.; Zhu, H.
Show abstract
Immune checkpoint inhibitor-induced myocarditis (ICIM) is a severe immune-related adverse event with heterogeneous clinical presentations and potential genetic susceptibility. Here, we established a human induced pluripotent stem cell (iPSC) line from an ICIM patient with an HLA-type distinct from previously reported line, who developed concurrent type I diabetes following ICI treatment. This line exhibited typical morphology, normal female karyotype, pluripotency, trilineage differentiation into all three germ layers, Sendai virus clearance, and no mycoplasma contamination. Given the fulminant nature and diverse clinical presentations of ICIM, expanding the repertoire of iPSC lines are critical for investigating ICIM heterogeneity and its underlying mechanisms.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Healthy human induced pluripotent stem cell-derived cardiomyocytes exhibit sex dimorphism even without the addition of hormones 92%
- A Serum- and Feeder-Free System to Generate CD4 and Regulatory T Cells from Human iPSCs 90%
- Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cells 90%
Similar papers in this journal
- Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model 91%
- Hypusinated eIF5A is expressed in pancreas and spleen of individuals with type 1 and type 2 diabetes 90%
- Replacing murine insulin 1 with human insulin protects NOD mice from diabetes 90%
Similar papers in this journal
- Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation 92%
- The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α 91%
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I 90%
Similar papers in this journal
- Divergent Cell-Type Specific Hypoxia Responses in Human Stem Cell-Derived and Primary Islets 92%
- Development of humanized mouse and rat models with full-thickness human skin and autologous immune cells 90%
- Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.